Quidel Corp., based in San Diego, announced it closed May 27 on the previously announced acquisition of Raritan-based Ortho Clinical Diagnostics Holdings PLC. The deal — which would create a new ...

• Fourth quarter Core revenue grew 3.5% to $518.9 million, or 4.3% in constant currency and 8.0% excluding CoV-2 assay sales • Fiscal year Core revenue grew 16.1% to $2.01 billion, or 14.6% in ...

Ortho Clinical Diagnostics (OCDX) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.19 per share a year ago.

Medical diagnostics firm Quidel Corporation plans to acquire Ortho Clinical Diagnostics, American Association for Clinical Chemistry reported March 1. The deal gives Quidel access to Ortho Clinical ...

RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...

Ortho Clinical Diagnostics, one of the world's largest pure-play in vitro diagnostics companies, announced the launch of the first quantitative Covid-19 IgG antibody test in addition to a total ...

Ortho Clinical Diagnostics today announced it will present seven scientific posters on its assays and display six products at its booth at the 2016 American Association for Clinical Chemistry (AACC) ...

(Reuters) - Private equity firm Carlyle Group LP is exploring a sale or initial public offering of Ortho-Clinical Diagnostics Inc, a U.S. diagnostics company that could be valued at more than $7 ...

Johnson & Johnson announced Thursday that it is selling its Ortho-Clinical Diagnostics business for $4.2 billion to the Carlyle Group. This continues a strategy to focus on growing businesses In a ...

Welcome to the Ortho Clinical Diagnostics first quarter 2022 earnings conference call and Webcast. [Operator instructions] Please note this conference is being recorded. An audio replay of the ...

Quidel Corp. reported a definitive agreement to acquire Ortho Clinical Diagnostics Holdings plc in a nearly $6 billion deal expected to close in the first half of 2022. The $24.68 per share offered by ...